Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Compliance of Patients Treated With Oral Route Anti Cancer Drugs.

NCT03630692 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.

NCT NCT03630692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03630692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Compliance of Patients Treated With Oral Route Anti Cancer Drugs.
Lead sponsor
Institut Cancerologie de l'Ouest
Phase
Observational
Overall status
Unknown status
Start date
March 25, 2016
Completion date
June 30, 2020
Enrollment
158 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cancer, stage iii renal cell cancer